Here is our artwork depicting our study in @Cell, showing dynamics between methylation of DNA (5mC) and RNA (m6A), regulating key genes during ES-to-EB differentiation.

See our artwork depicting the work, showing SRSF2 as a novel reader of m5C on RNA, leading to splicing (left). The specific cancer-prevalent mutation, P95H, attenuates SRSF2’s ability to read this modification, which prevents splicing, and thereby promoting leukemia (right).

What a great Christmas lab party! 🥳 We didn't break the bank but at least we had some pizzas 🍕 #Casinonight

Absolutely thrilled of this terrific #EEHD2 meeting. Outstanding speakers, great science, fabulous party. Can't wait for the next one! Thanks to everyone 🎉

Great first day at the #EEHD22, with amazing speakers! 🥳

What a memorable #labretreat with amazing people. Science and fun all in one! 🧬🎉

So delighted to be organizing this forefront conference about Epigenetics and Epigenomics in Health and Disease with some of the most amazing experts in the field. Come and join us in Brussels on 17-19 Nov 2022! precisionmedicineforum.com/o… #EEHD22 #Epigenetics #Epitranscriptomics

Cet article fait suite à notre récente apparition en Une du journal @LeVif

Merci @lalibrebe @MediaplanetBE pour l’interview au sein de notre laboratoire @ULBruxelles @JulesBordet et d’avoir mis en évidence le domaine de l’épigénétique et de son impact croissant pour traiter le cancer

At my first meeting, near Munich, since pandemic started. So good to be on the road again😃!